Novartis
Tracked across 18 events · 136 articles · First seen Apr 22, 2025 · Last active Jun 12, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
NewsDesk Dashboard
Business
Impact: Novartis announced the expansion of its community health programs to address gaps in heart disease and cancer care globally, which could positively impact its public image and long-term market position.
Apr 09, 2026 · 7 articles
Tech
Novartis presented new data from 31 abstracts across its immunology portfolio at the European Alliance of Associations for Rheumatology (EULAR) Congress in London from June 3-6, 2026. Key presentations included new data for Secukinumab>>> (secukinumab)…
Impact: As the company presenting the new data, Novartis's immunology portfolio is highlighted, potentially boosting its market position and future revenue prospects. The positive clinical trial results for its key drugs could lead to increased investor confidence.
May 31, 2026 · 6 articles
Business
Impact: Novartis settled a lawsuit with the estate of Henrietta Lacks over the unauthorized use of her cells, which were used to develop various medical advancements. This settlement resolves a significant legal and ethical challenge for Novartis.
Feb 26, 2026 · 7 articles
Regulatory
Impact: Novartis is among the pharmaceutical companies that agreed to lower drug prices for United States — Medicaid and cash payers as part of the deals with the Donald Trump administration.
Dec 19, 2025 · 7 articles
Tech
Impact: Novartis, the manufacturer of Onasemnogene abeparvovec, views this approval as a milestone in patient care and a reflection of its commitment to neurology and expanding its focus into neuroimmunology, neurodegenerative disorders, and neuromuscular diseases.
Dec 20, 2025 · 6 articles
International
Swiss companies have invested $27 billion in the United States between January and April, fulfilling a pledge made as part of a preliminary tariff agreement. This agreement, reached on November 14, saw former U.S. President…
Impact: Novartis is a key investor, announcing two U.S. projects: a biomedical research center in San Diego and a cancer-drug production facility in Texas.
Jun 07, 2026 · 7 articles
Domestic
Switzerland is holding a referendum on June 14 to vote on a proposal, championed by the right-wing Swiss People's Party, to cap its population at 10 million people. Supporters argue that the growing population strains…
Impact: Novartis, a major pharmaceutical company, has criticized the population cap, fearing it would exacerbate skilled worker shortages and harm the Swiss economy.
Jun 08, 2026 · 24 articles
Regulatory
Impact: Novartis made a similar investment in the United States earlier, setting a precedent that Roche is now following in response to the same market pressures.
Apr 22, 2025 · 6 articles
Tech
Impact: Novartis is using machine learning and advanced analytics to build intelligent manufacturing systems and integrate AI across production environments, showcasing the industry's move towards Pharma 4.0.
Apr 07, 2026 · 8 articles
International
Impact: Novartis employed Jason Thomas, a pharmaceutical researcher who was found dead after disappearing, adding a pharmaceutical link to the broader pattern of mysterious deaths.
Apr 11, 2026 · 6 articles
Domestic
The Switzerland>>> stock market closed modestly higher on Friday, with the benchmark SMI gaining between 0.28% and 0.35% across different sessions. This positive movement was largely attributed to sustained buying in several counters, notably Ant…
Impact: Novartis>>> shed 0.3%-0.7% in one session but moved up by 1.85% in another, showing mixed performance in the Switzerland>>> market.
May 21, 2026 · 8 articles
Business
Harbour BioMed>>> announced the appointment of Dhavalkumar Patel>>> as a Scientific Advisor. Dhavalkumar Patel>>> brings over two decades of experience in therapeutic innovation from roles at Sana Biotechnology>>>, EITC>>>, and Novartis>>>. His expertise is expected…
Impact: Dhavalkumar Patel>>> spent 10 years at Novartis>>> as Head of Research for NIBR Europe.
Jun 12, 2026 · 6 articles
Business
Impact: Novartis led AstronauTx's £48 million/$61 million Series A financing in October 2023.
May 12, 2026 · 6 articles
100
Novartis presented new dataNovartis presents positive...
90
Novartis highlighted data SecukinumabNovartis presents positive...
85
Novartis presented interim results IanalumabNovartis presents positive...
75
Novartis shared preliminary analysis Rap cellNovartis presents positive...
70
Novartis announced two projects United StatesSwiss Companies Invest $27...
60
Novartis criticized cap SwitzerlandSwitzerland Population Cap...
NEWSDESK
Track Novartis live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard